Soohyun Lee

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Rheumatoid Arthritis

Top Venues

Clinical drug investigation

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ombretta Viapiana, Soohyun Lee, Sangwook Yoon, Bruno Fautrel
Stepping Forward to the Next Level: Totality of Evidence for the First High-Concentration Adalimumab Biosimilar, CT-P17. Clinical drug investigation 42 (2) (2022)
Dasom Choi, Soohyun Lee, Seungmin Kim, Sangwook Yoon
A Developer's Perspective on Clinical Evidence and Benefits for Rituximab Biosimilar Uptake, with a Focus on CT-P10. Clinical drug investigation 42 (4) (2022)
Enrico Fusaro, Patrick Durez, Johannes Wohlrab, Soohyun Lee, Sangwook Yoon, Hubert Marotte
An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilar. Immunotherapy (2021)
Soohyun Lee, Heeyoung Lee, Eun Young Kim
Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin's Lymphoma: A Systematic Review and Meta-analysis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (5) (2020)